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Abstract: Fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG PET/CT) imaging, 
an established procedure for evaluation of malignancy, also shows increased FDG uptake in inflammatory conditions like 
tuberculosis. We present two patients, one renal cell carcinoma, post nephrectomy on follow up, evaluated to have 
cervical and mediastinal nodes diagnosed as tuberculosis and another case of disseminated tuberculosis mimicking 
metastasis. They were started on Anti tubercular therapy (ATT). Post 2 months treatment, FDG PET/CT showed 
response in most of the lesions.FDG PET/CT allows an easy evaluation of early therapeutic response in patients with 
TB, particularly extra-pulmonary TB. 
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CASE 1 
31 year old female underwent right nephrectomy for 
right renal cell carcinoma. She was refered for FDG 
PET/CT after 1 year for survelliance.FDG PET/CT was 
acquired after IV injection of 10 mCi of FDG. Scan 
showed bilateral supraclavicular nodes measuring 1 cm 
with an SUVmax of 6.6 along with mediastinal nodes 
with an Standardised Uptake Value (SUV)max of 7.6. 
Suspecting nodal metastasis, biopsy was done from 
supraclavicular lymph node which confirmed 
Tuberculosis. She was treated with ATT. After 2 
months, repeat FDG PET/CT was done which showed 
complete response to treatment. 
 
Figure 1: Maximum intensity projection (MIP) images of FDG 
PET/CT showing increased uptake in supraclavicular and 
mediastinal nodes. 
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Figure 2: Follow up FDG PET/CT images showing complete 
response to ATT with no residual disease. Physiological 
muscle uptake noted in right neck and vocal cord. 
CASE 2 
55 year old female presented with left renal mass 
lesion suspicious of malignancy. She was refered for 
FDG PET/CT for staging. FDG PET/CT showed uptake 
in the right renal mass lesion with an SUVmax of 6.Also 
increased uptake noted in multiple cervical, 
supraclavicular, medistinal and retroperitoneal lymph 
nodes. Intense uptake also noted in lung nodules and 
multiple bone lesions. In view of widespread 
metastasis, endobronchial ultrasound guided biopsy 
(EBUS) was taken from subcarinal node which showed 
tuberculosis. She was started on ATT. After 2 months, 
she underwent FDG PET/CT which showed complete 
metabolic response in renal lesion, lymph nodes and 
skeletal lesions except in lung nodule. 
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Figure 3: Maximum intensity projection (MIP) images of FDG 
PET/CT showing increased uptake in cervical, mediastinal, 
retroperitoneal nodes. Also increased uptake in multiple lung 
and bone lesions. 
 
Figure 4: Axial PET/CT showing uptake in the kidney lesion 
(arrow). 
 
Figure 5: Follow up FDG PET/CT images after 2 months 
showing response in all the lesions except lung nodule. 
DISCUSSION 
In routine practice, oncologic workup is responsible 
for the majority of referrals for whole-body FDG-
PET/CT. The indications in oncology include staging, 
restaging, assessment of therapy response, and 
detection of recurrence. In spite of the great success 
achieved by FDG-PET imaging in the evaluation of 
malignant disorders, the modality is not specific for the 
diagnosis of cancer [1]. It has been noted that 
processes such as infection and inflammation, and 
particularly granulomatous diseases, also cause 
increased FDG uptake in the affected tissues [2-6]. 
Tuberculosis (TB) is a chronic granulomatous 
inflammation caused by Mycobacterium tuberculosis. 
India accounts for nearly a third of the global burden of 
tuberculosis, with approximately 1.8 million new cases 
of tuberculosis reported every year [7]. Although it 
involves the thorax most frequently, any organ system 
in the body can be infected. The clinical and 
radiological features of tuberculosis are known to mimic 
those of many other diseases. The role of FDG 
PET/CT in TB and other inflammatory diseases is 
evolving and is not as yet clearly defined. 
At the same time, there is a considerable increase 
in FDG PET/CT referrals for patients with fever of 
unknown origin (FUO), generalized lymph node 
enlargement, and mediastinal or abdominal 
lymphadenopathy, especially when other investigations 
are inconclusive. The aim of such referrals is generally 
to rule out an underlying malignant disease or to detect 
an inflammatory pathology. Infections remain the most 
frequent cause of FUO, followed by neoplasms and 
noninfectious inflammatory diseases [8, 9]. In India, TB 
is known to be the commonest infection to present as 
FUO [10]. The high sensitivity of FDG PET/CT in 
detecting malignant lesions, infections, and other 
inflammatory processes alike, makes it an important 
tool that has the potential to play a role in the 
diagnostic protocol and management of patients with 
FUO [11, 12]. 
While performing FDG PET/CT for oncologic 
workup, we found TB to be a common cancer mimic, 
producing uptake patterns that are indistinguishable 
from that of cancer. Many studies have documented 
increased FDG uptake in active TB in diverse 
anatomical locations, mimicking malignant processes 
[13-17]. Our case also refered for PET/CT imaging to 
rule out metastasis in known case of cancer patients 
and incidentally found tuberculosis. Also FDG PET/CT 
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allows an easy evaluation of early therapeutic response 
in patients with TB, particularly extra-pulmonary TB as 
described in two studies [18, 19]. Our case also helped 
in response evaluation after ATT. 
With FDG-PET/CT imaging per se, based on semi 
quantitative analysis using SUV and the dual time point 
imaging technique, it is currently not possible to 
differentiate malignant lesions from active tuberculosis 
consistently. However, with an integrated FDG PET/CT 
technique, the CT scan images may help differentiate 
tuberculosis from malignant lesions, using morphologic 
criteria. The use of intravenous contrast increases this 
ability. In future, new, more specific radiotracers, like 
positron-emitter labeled antituberculous drug molecules 
may help to differentiate TB from cancer and 
nontuberculous inflammatory processes. 
CONCLUSION 
Due to the high prevalence of tuberculosis in India, 
false positive cases during oncologic workup with FDG-
PET/CT are commonly encountered in practice. 
Though FDG PET/CT is not specific for tuberculosis, it 
plays an important role in the evaluation of known or 
suspected TB cases. FDG PET/CT can determine the 
activity of lesions, guide biopsy from active sites, 
assess disease extent, detect occult distant foci, and 
evaluate response to therapy. Active tuberculous 
lesions often exhibit a high degree of FDG uptake, 
though this can vary, depending upon the grade of 
inflammatory activity and used in early response 
assesment to ATT. 
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